| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1334782-79-4 | 2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | C29H32N6OS |
| 1334890-93-5 | (1,10-Phenanthroline)(trifluoromethyl)(triphenylphosphine)copper(I) | C31H23CuF3N2P |
| 1335054-04-0 | Ethyl 6-bromo-4-chloronicotinate | C8H7BrClNO2 |
| 1335054-80-2 | 2-Bromo[1,2,4]triazolo[1,5-a]pyrimidine | C5H3BrN4 |
| 1335056-34-2 | 4-Bromo-3-pyridinemethanamine hydrochloride | C6H7BrN2.HCl |
| 1335057-22-1 | 5-Bromo-6-chloro-3-nitro-2-pyridinamine | C5H3BrClN3O2 |
| 1335095-08-3 | 3,4-Dihydro-1-hydroxy-1H-2,1-benzoxaborin-7-amine | C8H10BNO2 |
| 1335110-44-5 | Rosuvastatin EP impurity H | C23H31FN3O6S- |
| 1335116-38-5 | (3S)-1-(4-Piperidinyl)-3-pyrrolidinol | C9H18N2O |
| 1335117-26-4 | (3R)-1-(4-Piperidinyl)-3-pyrrolidinol | C9H18N2O |
| 1335202-59-9 | 2-[3-Cyano-4-(1-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid | C16H16N2O3S |
| 1335202-60-2 | 2-Isobutoxy-5-(4-methylthiazol-2-yl)benzonitrile | C15H16N2OS |
| 1335210-23-5 | 1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-methyl ester | C13H17NO8 |
| 1335210-24-6 | Cabotegravir Intermediate | C13H14N2O6 |
| 1335210-26-8 | Methyl 2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate | C11H19NO6 |
| 1335210-28-0 | 1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-ethyl 5-methyl ester | C15H21NO8 |
| 1335210-31-5 | Cabotegravir Impurity 9 | C11H11NO7 |
| 1335210-34-8 | (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid | C14H16N2O6 |
| 1335210-35-9 | (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | C21H21F2N3O5 |
| 1335316-40-9 | (5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline | C13H22N2O5 |
| 1335475-19-8 | 2-[[(Z)-[1-(2-Amino-4-thiazolyl)-2-oxo-2-[[(1,2,5,7-tetrahydro-5-methyl-7-oxo-4H-furo[3,4-d][1,3]thiazin-2-yl)methyl]amino]ethylidene]amino]oxy]acetic acid | C15H17N5O6S2 |
| 1335523-82-4 | (3S)-3-(4-Bromophenyl)piperidine | C11H14BrN |
| 1336893-15-2 | 2,6-Dibromo-4,8-bis[(2-butyloctyl)oxy]benzo[1,2-b:4,5-b']dithiophene | C34H52Br2O2S2 |
| 1337482-15-1 | N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-3'-uridylyl]-L-alanine 1-methylethyl ester | C22H29FN3O9P |
| 1337482-17-3 | Sofosbuvir impurity F | C34H45FN4O13P2 |
| 1337529-49-3 | N-[(2'R)-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-cytidylyl]-L-alanine 1-methylethyl ester | C22H30FN4O8P |
| 1337529-56-2 | N-[(R)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester | C18H17F5NO5P |
| 1337531-36-8 | 7-Methyl-5-[1-[[3-(trifluoromethyl)phenyl]acetyl]-2,3-dihydro-1H-indol-5-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C24H20F3N5O |
| 1337532-29-2 | 5-[4-Fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl]-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C23H21FN6O |
| 1337539-92-0 | (2E,2'E,4E,4'E)-2,4-Octadecadienoic acid 1,1'-[(1S)-1-(hydroxymethyl)-1,2-ethanediyl] ester | C39H68O5 |
| 1337879-54-5 | 5-(Cchloromethyl)pyrimidine hydrochloride | C5H5ClN2.HCl |
| 1337879-62-5 | 7-Bromo-4-methoxy-1H-indazole | C8H7BrN2O |
| 1337880-06-4 | 6-Bromo-7-methyl-1H-indazole | C8H7BrN2 |
| 1337880-32-6 | 4-Methoxy-1-methyl-1H-indazole | C9H10N2O |
| 1337881-26-1 | 4-Bromo-7-methyl-1H-indazol-3-amine | C8H8BrN3 |
| 1337882-06-0 | 3-Phenyl-1H-1,2,4-triazole-5-methanamine hydrochloride (1:2) | C9H10N4.2(HCl) |
| 1337883-32-5 | ((3-(3-Methyl-3H-diazirin-3-yl)propamino)carbonyl)-Nepsilon-L-lysine | C12H23N5O3 |
| 1337915-07-7 | 7,13-Dihydro-5,7,13,13-tetraphenyl-5H-indolo[3,2-b]acridine | C43H30N2 |
| 1337915-08-8 | 11,13-Dihydro-5,11,13,13-tetraphenyl-5H-indolo[2,3-b]acridine | C43H30N2 |
| 1337918-83-8 | Zavegepant | C36H46N8O3 |
| 1337967-93-7 | 5,5'-[(Tetrahydro-1H-1,4-diazepine-1,4(5H)-diyl)bis(sulfonyl)]bis[isoquinoline] | C23H22N4O4S2 |
| 1337992-05-8 | [4-(4-Propylcyclohexyl)-2-fluorophenyl]boronic acid | C15H22BFO2 |
| 1338075-15-2 | (5S)-1-Cyclopropyl-5-methyl-2-piperazinone hydrochloride (1:1) | C8H14N2O.HCl |
| 1338221-87-6 | (3alpha,17beta)-4-Chloro-17-methylandrosta-1,4-diene-3,17-diol | C20H29ClO2 |
| 1338225-97-0 | 3-Chloro-5-[[1-[(4,5-dihydro-4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]benzonitrile | C17H11ClF3N5O3 |
| 1338226-21-3 | 5-(Chloromethyl)-2,4-dihydro-4-methyl-3H-1,2,4-triazol-3-one | C4H6ClN3O |
| 1338247-30-5 | cyclopropanecarboxamide | C17H12Cl2F2N4OS |
| 1338247-35-0 | N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide | C17H14Cl2F2N4OS |
| 1338365-54-0 | 5-(2-Aminopropyl)-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile | C22H25N3O2 |
| 1338365-87-9 | 1,1'-[(Phenylimino)di-4,1-phenylene]bisethanone | C22H19NO2 |